Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D Mayer

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Biochimica Et Biophysica Acta|January 9, 2007
Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivoPaul G Tardi, Ryan C Gallagher, Sharon Johnstone, et al.
Methods in Enzymology|February 22, 2005
Preparation, characterization, and biological analysis of liposomal formulations of vincristineDawn N Waterhouse, Thomas D Madden, Pieter R Cullis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loadingSheela A Abraham, Cheryl McKenzie, Dana Masin, et al.
Methods in Enzymology|February 22, 2005
The liposomal formulation of doxorubicinSheela A Abraham, Dawn N Waterhouse, Lawrence D Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancerYanPing Hu, Gwyn Bebb, Sophia Tan, et al.
Leukemia & Lymphoma|June 10, 2010
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenograftsWah-Seng Lim, Paul G Tardi, Xiaowei Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivoYanPing Hu, Gabriele Cherton-Horvat, Visia Dragowska, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretionStephan T Stern, Peng Zou, Sarah Skoczen, et al.
Leukemia Research|December 26, 2016
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutationMax J Gordon, Paul Tardi, Marc M Loriaux, et al.
The Prostate|March 9, 2005
pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing miceEmma S Guns, Xiaowei Xie, Matthew Fedoruk, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Biochimica Et Biophysica Acta|January 9, 2007
Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivoPaul G Tardi, Ryan C Gallagher, Sharon Johnstone, et al.
Methods in Enzymology|February 22, 2005
Preparation, characterization, and biological analysis of liposomal formulations of vincristineDawn N Waterhouse, Thomas D Madden, Pieter R Cullis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loadingSheela A Abraham, Cheryl McKenzie, Dana Masin, et al.
Methods in Enzymology|February 22, 2005
The liposomal formulation of doxorubicinSheela A Abraham, Dawn N Waterhouse, Lawrence D Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2004
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancerYanPing Hu, Gwyn Bebb, Sophia Tan, et al.
Leukemia & Lymphoma|June 10, 2010
Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenograftsWah-Seng Lim, Paul G Tardi, Xiaowei Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivoYanPing Hu, Gabriele Cherton-Horvat, Visia Dragowska, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretionStephan T Stern, Peng Zou, Sarah Skoczen, et al.
Leukemia Research|December 26, 2016
CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutationMax J Gordon, Paul Tardi, Marc M Loriaux, et al.
The Prostate|March 9, 2005
pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing miceEmma S Guns, Xiaowei Xie, Matthew Fedoruk, et al.
Pageof 6